If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
3mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How to position an unconscious person following administration of Baqsimi™ (glucagon) nasal powder?
It is recommended to turn the person on their side after administering Baqsimi (glucagon) nasal powder.
US_cFAQ_NG059_POSITION_AFTER_ADMINISTRATION
en-US
Postadministration Position
If the person is unconscious, it is recommended to turn the person on their side after administering the dose of Baqsimi.1
Enclosed Prescribing Information
Reference
1Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.
Date of Last Review: January 14, 2022
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays